Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Coates

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Lancet (London, England)|August 11, 2001
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisB F Cole, R D Gelber, S Gelber, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Tailoring adjuvant treatments for the individual breast cancer patientR D Gelber, M Bonetti, M Castiglione-Gertsch, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2000
Systemic adjuvant treatment for premenopausal node-negative breast cancer. The International Breast Cancer Study GroupM Castiglione-Gertsch, R D Gelber, A O'Neill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysisA Goldhirsch, R D Gelber, R J Simes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast CancerA Goldhirsch, J H Glick, R D Gelber, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1987
Drug resistance in clinical practice: patterns of treatment failure in patients receiving systemic therapy for advanced breast cancerP R Harnett, M H Tattersall, A S Coates, et al.
British Journal of Cancer|November 15, 2000
Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanomaJ E Brown, P N Butow, G Culjak, et al.
The Journal of Hand Surgery|May 1, 1996
Subungual melanoma of the handM J Quinn, J E Thompson, K Crotty, et al.
Australian and New Zealand Journal of Medicine|February 1, 1977
Carcinoembryonic antigen in renal allograft recipients and immunosuppressed renal patientsJ B Myers, M Frost, A S Coates, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Lancet (London, England)|August 11, 2001
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisB F Cole, R D Gelber, S Gelber, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Tailoring adjuvant treatments for the individual breast cancer patientR D Gelber, M Bonetti, M Castiglione-Gertsch, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2000
Systemic adjuvant treatment for premenopausal node-negative breast cancer. The International Breast Cancer Study GroupM Castiglione-Gertsch, R D Gelber, A O'Neill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysisA Goldhirsch, R D Gelber, R J Simes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast CancerA Goldhirsch, J H Glick, R D Gelber, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1987
Drug resistance in clinical practice: patterns of treatment failure in patients receiving systemic therapy for advanced breast cancerP R Harnett, M H Tattersall, A S Coates, et al.
British Journal of Cancer|November 15, 2000
Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanomaJ E Brown, P N Butow, G Culjak, et al.
The Journal of Hand Surgery|May 1, 1996
Subungual melanoma of the handM J Quinn, J E Thompson, K Crotty, et al.
Australian and New Zealand Journal of Medicine|February 1, 1977
Carcinoembryonic antigen in renal allograft recipients and immunosuppressed renal patientsJ B Myers, M Frost, A S Coates, et al.
Pageof 15